Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme Appoints Pamela Strode as Vice President, Regulatory Affairs and Quality Assurance

CAMBRIDGE, Mass., Sept. 29, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, today...
September 21, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme Establishes Collaboration with Foundation Medicine to Support Tazemetostat Phase 2 Clinical Trial

CAMBRIDGE, Mass., Sept. 21, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapeutics, today announced that the...
September 15, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme Earns $6 Million Milestone Payment from GlaxoSmithKline for Initiation of Clinical Development with First-in-Class PRMT5 Inhibitor

CAMBRIDGE, Mass., Sept. 15, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapeutics, today announced it has earned a...
September 01, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Sept. 01, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that the Company...
August 11, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme Doses First Patient in Global Phase 2 Study Evaluating Tazemetostat in Mesothelioma

CAMBRIDGE, Mass., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that the first...
August 08, 2016 06:30 ET | Source: Epizyme, Inc.

Epizyme Announces Second Quarter 2016 Financial Results and Progress Against Corporate Objectives

Company Updates Financial Guidance Extending Runway into At Least Second Quarter of 2018 Conference Call to Be Held Today at 8:30 a.m. Eastern Time CAMBRIDGE, Mass., Aug. 08, 2016 (GLOBE...
August 01, 2016 16:05 ET | Source: Epizyme, Inc.

Epizyme to Report Second Quarter 2016 Financial Results on August 8, 2016 and Participate in Upcoming Wedbush PacGrow Healthcare Conference

CAMBRIDGE, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, announced today that...